Gender differences in pharmacokinetics and pharmacodynamics

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 11, 1999, Pages 529-547

  Beierle, I ^a,b   Meibohm, B ^a   Derendorf, H ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Gender differences; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; AZIMILIDE; BROMAZEPAM; CYTOCHROME P450; DIAZEPAM; ETOPOSIDE; GREPAFLOXACIN; IMIPRAMINE; INTESTINE ENZYME; LEVOFLOXACIN; LIPOPROTEIN; LIVER ENZYME; METHYLPREDNISOLONE; MIZOLASTINE; OFLOXACIN; ONDANSETRON; OROSOMUCOID; OXAZEPAM; PLASMA PROTEIN; PROGESTERONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERTINDOLE; SERTRALINE; TEMAZEPAM; THEOPHYLLINE; TIRILAZAD; TRIAZOLAM; VANCOMYCIN; ZOLMITRIPTAN;

ADULT; AGED; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL PHARMACOLOGY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; FEMALE; HORMONAL REGULATION; HUMAN; LIPOPHILICITY; MALE; MENSTRUAL CYCLE; PHARMACODYNAMICS; REVIEW; SEX DIFFERENCE;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; BODY WEIGHT; CLINICAL TRIALS; FEMALE; HORMONES; HUMANS; MALE; MENSTRUAL CYCLE; PHARMACOKINETICS; PHARMACOLOGY; SEX FACTORS; TIME FACTORS;

EID: 0032695638     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Aarons L, Hopkins K, Rowland M, Brossel S, Thiercelin JF 1989 Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt. Pharm Res 6: 660-666
2. Abad-Santos F, Carcas AJ, Guerra P, Govantes C, Montuenga C, Gomez E, Fernandez A, Frias J 1996 Evaluation of sex differences in the pharmacokinetics of ranitidine in humans. J Clin Pharmacol 36: 748-751
3. Ammon E, Schafer C, Hofmann U, Klotz U 1996 Disposition and first-pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender? Clin Pharmacol Ther 59: 503-513
4. Back DJ, Orme ML 1990 Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet 18: 472-484
5. Bonate PL 1991 Gender-related differences in xenobiotic metabolism. J Clin Pharmacol 31: 684-690
6. Boni JP, DeCleene SA, Cevallos WH, Hicks DR, Korth Bradley JM 1997 Effects of age and gender on the pharmacokinetics of bromfenac in healthy volunteers. Ann Pharmacother 31: 400-405
7. Braeckman RA, Granneman GR, Locke CS, Machinist JM, Cavannaugh JH, Awni WM 1995 The pharmacokinetics of zileuton in healthy young and elderly volunteers. Clin Pharmacokinet 29 (Suppl 2): 42-48
8. Brocks DR, Upward J, Hust R, Koester FE, Collie H, Qian Y, Dennis MJ 1996 The pharmacokinetics of pranlukast in healthy young and elderly subjects. Int J Clin Pharmacol Ther 34: 375-379
9. Campbell NR, Hull RD, Brant R, Hogan DB, Pineo GF, Raskob GE 1998 Different effects of heparin in males and females. Clin Invest Med 21: 71-78
10. Cheng H, Rogers JD, Sweany AE, Dobrinska MR, Stein EA, Tate AC, Amin AD, Quan H 1992 Influence of age and gender on plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A [HMG-CoA] reductase inhibitory activity following multiple doses lovastatin and simvastatin. Pharm Res 9: 1629-1633
11. Chien SC, Chow AT, Natarajan J, William RR, Wong FA, Rogge MC, Nayak RK 1997 Absence of age and gender effects on the pharmacokinetics of a single 500 milligram oral dose of levofloxacin in healthy subjects. Antimicrob Agents Chemother 41: 1562-1565
12. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K, Pedersen O 1996 Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98: 1195-1209
13. Conley BA, Egofin MJ, Sridhara R, Finley R, Hemady R, Wu S, Tait NS, Van Echo DA 1997 Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics. Cancer Chemother Pharmacol 39: 291-299
14. Corey A, Agnew J, Bao J, Bryson P, Comer P, Griffith S, Li J 1997 Effect on age and gender on azimilide pharmacokinetics after a single oral dose of azimilide dihydrochloride. J Clin Pharmacol 37: 946-953
15. Dahl ML, Bertilsson L, Nordin C 1996 Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype. Psychopharmacology Berl 123: 315-319
16. D'Arcy PF 1986 Drug interactions with oral contraceptives. Drug Intell Clin Pharm 20: 353-362
17. De Groot AN, Vree TB, Hekster YA, Van Den Biggelaar MM, Van Dongen PW, Van Roosmalen J 1995 Comparison of the bioavailability and pharmacokinetics of oral methylergometrine in men and women. Int J Clin Pharmacol Ther 33: 328-332
18. De Vos JW, Geerlings PJ, Van Den Brink W, Ufkes JG, Van Wilgenburg H 1995 Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. Eur J Clin Pharmacol 48: 361-366
19. Derendorf H, Meibohm B 1999 Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives. Pharm Res 16: 176-185
20. Dobbs NA, Twelves CJ, Gillies H, James CA, Harper PG, Rubens RD 1995 Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry. Cancer Chemother Pharmacol 36: 473-476
21. Drover DR, Lemmens HJ 1998 Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology 89: 869-877
22. Duchanne MP, Slaughter RL, Edwards DJ 1994 Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit 16: 513-518
23. Efthymiopoulos C, Bramer SL, Maroli A 1997 Effect of age and gender on the pharmacokinetics of grepafloxacin. Clin Pharmacokinet 33: 9-17
24. Fleishaker JC, Pearson LK, Pearson PG, Wienkers LC, Hopkins NK, Peters GR 1999 Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A. J Clin Pharmacol 39: 260-267
25. Fleishaker JC, Pearson LK, Peters GR 1996 Gender does not affect the degree of induction of tirilazad clearance by phenobarbital. Eur J Clin Pharmacol 50: 139-145
26. Fleishaker JC, Pearson PG, Wienkers LC, Pearson LK, Moore TA, Peters GR 1998 Biotransformation of tirilazad in human: 4. effect of finasteride on tirilazad clearance and reduced metabolite formation. J Pharmacol Exp Ther 287: 591-597
27. Fletcher CV, Acosta EP, Strykowski JM 1994 Gender differences in human pharmacokinetics and pharmacodynamics. J Adolesc Health 15: 619-629
28. Frackiewicz EJ, Sramek JJ, Herrera JM, Kurtz NM, Cutler NR 1997 Ethnicity and antipsychotic response. Ann Pharmacother 31: 1360-1369
29. Frezza M, Di Padova C, Pozatto G, Terpin M, Baraona E, Lieber CS 1990 High blood ethanol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322: 95-99
30. Gallicano K, Sahai J 1996 Lack of gender effect on ciprofloxacin pharmacokinetics in humans. Br J Clin Pharmacol 42: 632-634
31. Gaudry SE, Sitar DS, Smyth DD, McKenzie JK, Aoki FY 1993 Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. Clin Pharmacol Ther 54: 23-27
32. Gibson DM, Bron NJ, Richens A, Hounslow NJ, Sedman AJ, Whiffield LR 1996 Effect of age and gender on pharmacokinetics, of atorvastatin in humans. J Clin Pharmacol 36: 242-246
33. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI 1984 Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 61: 27-35
34. Gupta SK, Atkinson L, Tu T, Longstreth JA 1995 Age-and gender-related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil. Br J Clin Pharmacol 40: 325-331
35. Harris RZ, Benet LZ, Schwartz JB 1995 Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50: 222-239
36. Hartter S, Wetzel H, Hammes E, Hiemke C 1993 Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients. Psychopharmacology 110: 302-308
37. Hartter S, Wetzel H, Hammes E, Torkzadeh M, Hiemke C 1998 Nonlinear pharmacokinetics of fluvoxamine and gender differences. Ther Drug Monit 20: 446-449
38. Heykants J, Van Peer A, Van de Velde V, Snoeck E, Meuldermans W, Woestenborghs R 1995 The pharmacokinetic properties of topical levocabastine. A review. Clin Pharmacokinet 29: 221-230
39. Ho PC, Triggs EJ, Bourne DW, Heazlewood VJ 1985 The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites. Br J Clin Pharmacol 19: 675-684
40. Hulst LK, Fleishaker JC, Peters GR, Harry JD, Wright DM, Ward P 1994 Effect of age and gender on tirilazad pharmacokinetics in humans. Clin Pharmacol Ther 55: 378-384
41. Hussein Z, Eaves J, Hutchinson DB, Canfield CJ 1997 Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin Pharmacol Ther 61: 518-530
42. Hussein Z, Posner J 1997 Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Br J Clin Pharmacol 43: 457-465
43. Jann MW, Zum, Brunnen TL, Tenjarla SN, Ward ES Jr, Weidler DJ 1998 Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences. Pharmacotherapy 18: 288-294
44. Jokubaitis LA 1996 Development and pharmacology of fluvastatin. Br J Clin Pract Suppl 77a: 11-15
45. Kando JC, Yonkers KA, Cole JO 1995 Gender as a risk factor for adverse events to medications. Drugs 50: 1-6
46. Karim A, Noveck R, McMahon FG, Smith M, Crosby S, Adams M, Wilton J 1997 Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics. J Clin Pharmacol 37: 267-278
47. Kashuba AD, Nafziger AN 1998 Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs. Clin Pharmacokinet 34: 203-218
48. Kaul S, Sfinivas NR, Igwemezie LN, Barbhaiya RH 1996a A pharmacodynamic evaluation of hematologic toxicity observed with etoposide phosphate in the treatment of cancer patients. Semin Oncol 23: 15-22
49. Kaul S, Sfinivas NR, Mummaneni V, Igwemezie LN, Barbhaiya RH 1996b Effects of gender, age, and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients. Semin Oncol 23: 23-29
50. Klamerus KJ, Parker VD, Rudolph RL, Derivan AT, Chiang ST 1996 Effects of age and gender on venlafaxine and 0-desmethylvenlafaxine pharmacokinetics. Pharmacotherapy 16: 915-923
51. Knights KM, McLean CF, Tonkin AL, Miners JO 1995 Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans. Br J Clin Pharmacol 40: 153-156
52. Korth-Bradley JM, Rose GM, de Vane PJ, Peters J, Chiang ST 1996 Population pharmacokinetics of intravenous amiodarone in patients with refractory ventricular tachycardia/fibrillation. J Clin Pharmacol 36: 715-719
53. Lane HY, Chang YC, Chang WH, Lin SK Tseng YT, Jann MW 1999 Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics. J Clin Psychiatry 60: 36-40
54. Lehmann MH, Hardy S, Archibald D, MacNeil DJ 1999 JTc prolongation with d,l-sotalol in women versus men. Am J Cardiol 83: 354-359
55. Levey A, Madaio M, Perrone R 1991 Laboratory assessment of renal disease: clearance, urinanalysis, and renal biopsy. In: Brenner B, Rector FJ (eds) The Kidney. Saunders, Philadelphia, 922
56. Levy G 1998 Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability. Clin Pharmacokinet 34: 323-333
57. Lew KH, Ludwig EA, Milad MA, Donovan K, Middleton E Jr, Ferry JJ, Jusko WJ 1993 Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 54: 402-414
58. Loi CM, Parker BM, Cusack B, Vestal RE 1997 Aging and drug interactions. III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers. J Pharmacol Exp Ther 280: 627-637
59. Lukkari E, Hakonen T, Neuvonen PJ 1998 The pharmacokinetics of oxybutynin is unaffected by gender and contraceptive steroids. Eur J Clin Pharmacol 53: 351-354
60. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH 1993 Female gender as a risk factor for torsade de pointes associated with cardiovascular drugs. JAMA 270: 2590-2597
61. Marathe PH, Greene, DS, Kollia GD, Barbhaiya RH 1997 The effects of age and gender on single dose pharmacokinetics of avitriptan administered to healthy volunteers. J Clin Pharmacol 37: 937-945
62. Marathe PH, Greene DS, Lee JS, Barbhaiya RH 1998 Assessment of effect of food, gender, and intra-subject variability in the pharmacokinetics of avitriptan. Biopharm Drug Dispos 19: 153-157
63. Massana E, Barbanoj MJ, Moros C, Morte A, Gich I, Jane F 1997 No sex-related pharmacokinetic and pharmacodynamic differences of captopril. Pharmacol Res 36: 41-47
64. Merkatz RB, Temple R, Subel S, Feiden K, Kessler DA 1993 Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials. N Engl J Med 329: 292-296
65. Mesnil F, Mentre F, Dubruc C, Thenot JP, Mallet A 1998 Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood method. J Pharmacokinet Biopharm 26: 133-161
66. Michalets EL 1998 Update: clinically significant cytochrome P450 drug interactions. Pharmacotherapy 18: 84-112
67. Minora T, Ventresca GP, Madani L 1990 Problems of pharmacokinetics in pregnancy. A bibliographic review. Ann Obstet Ginecol Med Perinat 111: 159-173
68. Minto CF, Schnider TIN, Egan TD, Youngs E, Lemmens HJ, Gambus PL, Billard V, Hoke JF, Moore KH, Hermann DJ, Muir KT, Mandema JIM, Shafer SL 1997 Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 86: 10-23
69. Mohamed MH, Lima JJ, Eberle LV, Self TH, Johnson JA 1999 Effects of gender and race on albuterol pharmacokinetics. Pharmacotherapy 19: 157-161
70. Nau H 1985 Clinical pharmacokinetics in pregnancy and perinatology. I. Placental transfer and fetal side effects of local anaesthetic agents. Dev Pharmacol Ther 8: 149-181
71. Nau H 1987 Clinical pharmacokinetics in pregnancy and perinatology. II. Penicillins. Dev Pharmacol Ther 10: 174-198
72. Nuutila P, Knuuti MJ, Maki M, Laine H, Ruotsalainen U, Teras M, Haaparanta M, Solin O, Yki Jarvinen H 1995 Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 44: 31-36
73. Pan HY, Waclawski AP, Funke PT, Whigan D 1993 Pharmacokinetics of pravastatin in elderly versus young men and women. Ann Pharmacother 27: 1029-1033
74. Parker CJ, Hunter JM, Snowdon SL 1993 Effect of age, gender and anaesthetic technique on the pharmacodynamics of atracurium. Br J Anaesth 70: 38-41
75. Peck RW, Seaber EJ, Dixon RM, Layton GR, Weatherley BC, Jackson SH, Rolan PE, Posner J 1998 The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women. Clin Pharmacol Ther 63: 342-353
76. Pollock BG 1997 Gender differences in psychotropic drug metabolism. Psychopharmacol Bull 33: 235-241
77. Pratt CM, Camm AJ, Cooper W, Friedman PL, MacNeil DJ, Moulton KM, Pitt B, Schwartz PJ, Veltri EP, Waldo AL 1998 Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? Am J Cardiol 81: 869-876
78. Preskorn SH 1997 Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet 32 (Suppl 1): 1-21
79. Pritchard JF, Bryson JC, Kernodle AE, Benedetti TL, Powell JR 1992 Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers. Clin Pharmacol Ther 51: 51-55
80. Reigner BG, Welker HA 1996 Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studies. Antimicrob Agents Chemother 40: 575-580
81. Relling MV, Lin JS, Ayers GD, Evans WE 1992 Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther 52: 643-658
82. Ronfeld RA, Tremaine LM, Wilner KD 1997 Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet 32 (Suppl 1): 22-30
83. Rowland M, Tozer T 1995 Clinical pharmacokinetics. Williams and Wilkins, Media, PA
84. Saenz Campos D, Bayes MC, Martin S, Barbanoj MJ, Jane F 1995 Gender related pharmacokinetics of diltiazem in healthy subjects. Int J Clin Pharmacol Ther 33: 397-400
85. Salazar DE, Much DR, Nichola PS, Seibold JR, Shindler D, Slugg PH 1997 A pharmacokinetic-pharmacodynamic model of d-sotalol QTc prolongation during intravenous administration to healthy subjects. J Clin Pharmacol 37: 799-809
86. Salva P, Costa J 1995 Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet 29: 142-153
87. Sambol NC, Chiang J, M OC, Liu CY, Lin ET, Goodman AM, Benet LZ, Karam JH 1996 Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus. J Clin Pharmacol 36: 1012-1021
88. Sasaki M, Tateishi T, Ebihara A 1993 The effects of age and gender on the stereoselective pharmacokinetics of verapamil. Clin Pharmacol Ther 54: 278-285
89. Scavone JM, Greenblatt DJ, Harmatz JS, Engelhardt N, Shader RI 1998 Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers. J Clin Pharmacol 38: 603-609
90. Schmidt ME, Matochik JA, Goldstein DS, Schouten A, Zametkin AJ, Potter WZ 1997 Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade. Neuropsychopharmacology 16: 298-310
91. Schmith VD, Fiedler-Kelly J, Phillips L, Grasela TH 1997 Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium. Pharm Res 14: 91-97
92. Schuetz EG, Furuya KN, Schuetz JD 1995 Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275: 1011-1018
93. Seaber E, On N, Dixon RM, Gibbens M, Leavens WJ, Liptrot J, Chittick G, Posner J, Rolan PE, Pack RW 1997 The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90). Br J Clin Pharmacol 43: 579-587
94. Shenfield GM 1993 Oral contraceptives. Are drug interactions of clinical significance? Drug Saf 9: 21-37
95. Smith DA, Cleary EW, Watkins S, Huffman CS, Dilzer SC, Lasseter KC 1998 Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: a double-blind, placebo-controlled study. J Clin Pharmacol 38: 685-693
96. Sowinski KM, Abel SR, Clark WR, Mueller BA 1999 Effect of gender on the pharmacokinetics of ofloxacin. Pharmacotherapy 19: 442-446
97. Suri A, Forbes WP, Bramer SL 1998 Pharmacokinetics of multiple-dose oral cilostazol in middle-aged and elderly men and women. J Clin Pharmacol 38: 144-150
98. Tenero DM, Martin DE, Miller AK, Ilson B, Boike SC, Zariffa N, Jorkasky DK 1998 Effect of age and gender on the pharmacokinetics of eprosartan. Br J Clin Pharmacol 46: 267-270
99. Thomasson HR 1995 Gender differences in alcohol metabolism. Physiological responses to ethanol. Recent Dev Alcohol 12: 163-179
100. Thummel KE, D OS, Paine MF, Shen DD, Kunze KL, Perkins JD, Wilkinson GR 1996 Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 59: 491-502
101. Thurmann PA, Hompesch BC 1998 Influence of gender on the pharmacokinetics and pharmacodynamics of drugs. Int J Clin Pharmacol Ther 36: 586-590
102. Tracy TS, Korzekwa KR, Gonzalez FJ, Wainer IW 1999 Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. Br J Clin Pharmacol 47: 545-552
103. Vachharajani NN, Shyu WC, Smith RA, Greene DS 1998 The effects of age and gender on the pharmacokinetics of irbesartan. Br J Clin Pharmacol 46: 611-613
104. Walker JS, Carmody JJ 1998 Experimental pain in healthy human subjects: gender differences in nociception and in response to ibuprofen. Anesth Analg 86: 1257-1262
105. Wienkers LC, Steenwyk RC, Pearson PG 1996 Biotransformation of tirilazad in humans. 1. Cytochrom P450 3A mediated hydroxylation of tirilazed mesylate in human liver microsom. J Pharmacol Exp Ther 277: 992-990
106. Wilson K 1984 Sex-related differences in drug disposition in man. Clin Pharmacokinet 9: 189-202
107. Wong LT, Sitar DS, Aoki FY 1995 Chronic tobacco smoking and gender as variables affecting amantadine disposition in healthy subjects. Br J Clin Pharmacol 39: 81-84
108. Wong SL, Cao G, Mack RJ, Granneman GR 1997 Pharmacokinetics of sertindole in healthy young and elderly male and female subjects. Clin Pharmacol Ther 62: 157-164
109. Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC, Grebow P 1999 Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. J Clin Pharmacol 39: 281-288
110. Wright CE, Sisson TL, Ichhpurani AK, Peters GR 1997 Steady-state pharmacokinetic properties of pramipexole in healthy volunteers. J Clin Pharmacol 37: 520-525
111. Yonkers KA, Kando JC, Cole JO, Blumenthal S 1992 Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 149: 587-595
112. Yu DK, Nordbrock E, Hutcheson SJ, Lewis EW, Sullivan W, Bhargava VO, Weir SJ 1995 Population pharmacokinetics of teicoplanin in patients with endocarditis. J Pharmacokinet Biopharm 23: 25-39
113. Yukawa E, Higuchi S, Mine H 1992 Digoxin population pharmacokinetics; from routine clinical data: role of patient characteristics for estimating dosing regimens. J Pharm Pharmacol 44: 761-765
114. Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T 1997 Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update. J Clin Pharmacol 37: 92-100